Shu‐Chi Wang

2.7k citations
87 papers · 1.9k indexed · h-index 23

Impact in

    • Cancer, Hypoxia, and Metabolism
    • MicroRNA in disease regulation
  • Immunology top 5%
    • Immune cells in cancer
    • Immunotherapy and Immune Responses

Papers in

    • Hepatitis C virus research 14
    • Cancer, Hypoxia, and Metabolism 7
    • Cancer, Lipids, and Metabolism 6

Shu‐Chi Wang

86 papers receiving 1.9k citations

Peers

Shu‐Chi Wang
Comparison fields: 5 of 116
  • Cancer Research 436
  • Immunology 520
  • Genetics 211
  • Neurology 150
  • Oncology 367
Replace Yuanyuan Zhang with:
Yuanyuan Zhang China
Yung‐Luen Yu Taiwan
Amy Simon United States
Wen Peng China
Karsten Gülow Germany
Jong Kyu Woo South Korea
Quansheng Zhou China
Oluwaseun Adebayo Bamodu Taiwan
Shu‐Chi Wang relative to Yuanyuan Zhang China Yuanyuan Zhang's profile →
Citations per field
00.5×1.5×2.1×
Yuanyuan Zhang · 1×
Citations per year

Countries citing papers authored by Shu‐Chi Wang

Since Specialization
Citations

This map shows the geographic impact of Shu‐Chi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Chi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Chi Wang more than expected).

Fields of papers citing papers by Shu‐Chi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Chi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Chi Wang. The network helps show where Shu‐Chi Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Shu‐Chi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shu‐Chi Wang Line = papers co-authored together Shu‐Chi Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2010164
2 2012160
3 2011145
4 2019138
5 2017129
6 201399
7 201870
8 201866
9 202148
10 201048
11 201947
12 201043
13 201837
14 200634
15 201632
16 202228
17 202127
18 202127
19 202022
20 201122

About Shu‐Chi Wang

Shu‐Chi Wang is a scholar working on Hepatology, Cancer Research, Toxicology, Immunology and Neurology, having authored 87 papers that have together received 1.9k indexed citations. Recurring topics across this work include Hepatitis C virus research (14 papers), Liver Disease Diagnosis and Treatment (11 papers), Prostate Cancer Treatment and Research (9 papers), Immune cells in cancer (9 papers), Cancer, Hypoxia, and Metabolism (7 papers), Inflammasome and immune disorders (7 papers), Cancer, Lipids, and Metabolism (6 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). The work is most often cited by research in Cancer Research (436 citations), Immunology (520 citations), Genetics (211 citations), Neurology (150 citations) and Oncology (367 citations). Shu‐Chi Wang has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Chi‐Shiun Chiang, Ji‐Hong Hong, Chia‐Yang Li, Wei‐Chung Cheng, Po‐Len Liu, Ching‐Fang Yu, George T.Y. Chen, Chuen Hsueh, Shih‐Hua Fang and Elizabeth W. Newcomb. Their work appears in journals such as Scientific Reports, Biomedicine & Pharmacotherapy, International Journal of Molecular Sciences, Frontiers in Pharmacology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026